Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 Jan;53(1):41–43. doi: 10.1136/jcp.53.1.41

Cervical cytology after 2000: where to go?

C Meijer 1, J Walboomers 1
PMCID: PMC1731046  PMID: 10767855

Full Text

The Full Text of this article is available as a PDF (74.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team. Lancet. 1999 Apr 24;353(9162):1381–1385. [PubMed] [Google Scholar]
  2. Bistoletti P., Zellbi A., Moreno-Lopez J., Hjerpe A. Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III. Cancer. 1988 Nov 1;62(9):2056–2059. doi: 10.1002/1097-0142(19881101)62:9<2056::aid-cncr2820620931>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  3. Bollen L. J., Tjong-A-Hung S. P., van der Velden J., Mol B. W., ten Kate F. W., ter Schegget J., Bleker O. P. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol. 1999 Feb;72(2):199–201. doi: 10.1006/gyno.1998.5250. [DOI] [PubMed] [Google Scholar]
  4. Carpenter A. B., Davey D. D. ThinPrep Pap Test: performance and biopsy follow-up in a university hospital. Cancer. 1999 Jun 25;87(3):105–112. doi: 10.1002/(sici)1097-0142(19990625)87:3<105::aid-cncr2>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  5. Chua K. L., Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol. 1997 Jul;66(1):108–113. doi: 10.1006/gyno.1997.4753. [DOI] [PubMed] [Google Scholar]
  6. Contegiacomo A., Pizzi C., De Marchis L., Alimandi M., Delrio P., Di Palma E., Petrella G., Ottini L., French D., Frati L. High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers. Int J Cancer. 1995 Mar 29;61(1):1–6. doi: 10.1002/ijc.2910610102. [DOI] [PubMed] [Google Scholar]
  7. Elfgren K., Bistoletti P., Dillner L., Walboomers J. M., Meijer C. J., Dillner J. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol. 1996 Mar;174(3):937–942. doi: 10.1016/s0002-9378(96)70330-7. [DOI] [PubMed] [Google Scholar]
  8. Hakama M., Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv. 1988;7(3):403–416. [PubMed] [Google Scholar]
  9. Jacobs M. V., Snijders P. J., Voorhorst F. J., Dillner J., Forslund O., Johansson B., von Knebel Doeberitz M., Meijer C. J., Meyer T., Nindl I. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol. 1999 Jul;52(7):498–503. doi: 10.1136/jcp.52.7.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Leiman G. Thin-layer cytology meets viral hybrid capture. Adv Anat Pathol. 1999 May;6(3):161–164. doi: 10.1097/00125480-199905000-00005. [DOI] [PubMed] [Google Scholar]
  11. Manos M. M., Kinney W. K., Hurley L. B., Sherman M. E., Shieh-Ngai J., Kurman R. J., Ransley J. E., Fetterman B. J., Hartinger J. S., McIntosh K. M. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999 May 5;281(17):1605–1610. doi: 10.1001/jama.281.17.1605. [DOI] [PubMed] [Google Scholar]
  12. Meijer C. J., van den Brule A. J., Snijders P. J., Helmerhorst T., Kenemans P., Walboomers J. M. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ. 1992;(119):271–281. [PubMed] [Google Scholar]
  13. Nobbenhuis M. A., Walboomers J. M., Helmerhorst T. J., Rozendaal L., Remmink A. J., Risse E. K., van der Linden H. C., Voorhorst F. J., Kenemans P., Meijer C. J. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999 Jul 3;354(9172):20–25. doi: 10.1016/S0140-6736(98)12490-X. [DOI] [PubMed] [Google Scholar]
  14. Rozendaal L., Walboomers J. M., van der Linden J. C., Voorhorst F. J., Kenemans P., Helmerhorst T. J., van Ballegooijen M., Meijer C. J. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996 Dec 11;68(6):766–769. doi: 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  15. Sawaya G. F., Grimes D. A. New technologies in cervical cytology screening: a word of caution. Obstet Gynecol. 1999 Aug;94(2):307–310. doi: 10.1016/s0029-7844(99)00289-6. [DOI] [PubMed] [Google Scholar]
  16. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES